Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an adult with Kawasaki's disease

Raj H. Chandwaney, Tom Stathopoulos, John Sunew, David McPherson, Charles J. Davidson*

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Kawasaki's disease is an acute systemic vasculitic syndrome that primarily affects children. Coronary aneurysms are common vasculitic sequelae of Kawasaki's disease. Intracoronary thrombosis and embolization are potential consequences of coronary aneurysms. We describe our experience of successful thrombolysis using the combination of reduced-dose intravenous tissue plasminogen activator and abciximab as described in the Thrombolysis in Myocardial Infarction 14 trial (TIMI 14) to treat a patient found to have intracoronary thrombus at the site of aneurysm formation due to Kawasaki's disease.

Original languageEnglish (US)
Pages (from-to)651-653
Number of pages3
JournalJournal of Invasive Cardiology
Volume13
Issue number9
StatePublished - Sep 1 2001

Keywords

  • Coronary aneurysm
  • Glycoprotein IIb/IIIa inhibitors
  • Thrombolytics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Successful thrombolysis using the combination of tissue plasminogen activator and abciximab in an adult with Kawasaki's disease'. Together they form a unique fingerprint.

  • Cite this